Northwell and Fidelis Are Out of Network — And Every Provider Should Be Paying Attention to Why

As of July 16, roughly 240,000 people in the New York metro area lost in-network access to Northwell Health, the state’s largest health system, if their coverage runs through Fidelis Care. A continuity-of-care window keeps some patients covered through mid-August, but for a large share of Fidelis’s Medicaid, Medicare Advantage (Wellcare), and Essential Plan members, providers they’ve used for years are now technically out of network. This is not a small commercial contract lapsing quietly. It’s one of the largest payer-provider breakups New York has seen in years, and the dynamics behind it are worth understanding regardless of which side of the negotiating table your organization sits on.

The public positions are, predictably, incompatible. Northwell says Fidelis proposed reimbursement rates below the actual cost of delivering care and that the insurer owes the system a substantial sum in unpaid claims. Fidelis, owned by Centene, says Northwell is demanding rates well above what comparable systems accept in the market, and that agreeing to those terms isn’t sustainable for a program funded largely by taxpayers. Both claims can be true simultaneously, and that’s precisely what makes disputes like this so hard to resolve: there’s no neutral arbiter sitting between a health system and an insurer when a contract lapses, only two parties with legitimate but conflicting financial positions, and a population of patients with no formal seat at that table.

What distinguishes this dispute from a routine contract renewal is the payer mix. This isn’t a boutique commercial plan losing access to a handful of out-of-area specialists. This is Medicaid, Medicare Advantage, and Essential Plan enrollees — populations that are, on average, less equipped to absorb a sudden network disruption. They’re less likely to have the time, resources, or health literacy to identify and vet new specialists inside a compressed continuity-of-care window, and more likely to be managing chronic conditions where switching providers mid-treatment carries real clinical risk. Local coverage has already surfaced individual cases illustrating exactly this problem — patients managing multiple chronic conditions who depend on specific specialists and describe the transition window as an unreasonable burden to navigate on short notice.

There’s a broader signal in this dispute for anyone tracking payer-provider dynamics more generally, and it has direct relevance for smaller practices watching from the sidelines. Disputes of this scale and this much public visibility tend to happen when one side calculates it has more leverage than the prior negotiation reflected. Increasingly, large health systems are willing to let a termination deadline pass rather than accept rates they consider below cost, betting that public pressure, regulatory scrutiny, and continuity-of-care obligations will eventually pull the payer back to the table on improved terms. Whether that bet pays off for Northwell remains genuinely uncertain — as of this writing, both organizations describe themselves as open to reaching an agreement, but no deal has been announced, and the transition deadline is approaching fast for affected members.

For independent and mid-size practices, the Northwell-Fidelis standoff is a useful preview of where payer negotiations are trending industry-wide. Health systems with real negotiating leverage are increasingly willing to go public and go out-of-network rather than accept rates they view as unsustainable, and insurers — squeezed by their own margin pressures on government programs — are increasingly willing to let that happen rather than concede on rate. A smaller practice without Northwell’s negotiating leverage doesn’t have the option of letting a contract lapse publicly and waiting out the payer. But the underlying lesson still applies: rate disputes are increasingly playing out through public statements, patient-facing FAQs, and media coverage rather than being quietly resolved before a termination deadline, and if a contract renewal is approaching and the numbers aren’t moving in your own negotiations, it’s worth assuming the disagreement will become visible to patients well before it gets resolved.

There’s also a compliance dimension worth flagging for any practice or facility with patients caught in the middle of this specific dispute, or a similar one elsewhere. Continuity-of-care protections under New York insurance law generally require payers to cover ongoing treatment with an out-of-network provider for a defined transition period when a contract terminates, particularly for patients in active treatment, pregnant patients, and those with chronic conditions. Practices with affected patients should be documenting continuity-of-care eligibility now, not waiting for a denial to trigger that conversation, and should be prepared to help patients file complaints with the New York State Department of Financial Services if Fidelis fails to honor those protections during the transition window.

Sources: